yep. Lots of potential still, but your right in that a hard nosed investor would assess the years since the 17c cap raise and judge us against where we should be now, ie…
- well underway in clinic by now for rp11, some efficacy readouts before ‘22 Xmas (was the hope anyway) - ADOA lead defined and IND tucked away - CNS lead defined and IND in sights - pipeline leads clearly defined
I still believe, and hope that the $8.5m was spent well last quarter, but I realise that hope is now my main descriptor for PYC
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)